Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ZYDUS PHARMS USA INC

  • FDA Approval
  • Jan. 17, 2024, 09:53 UTC
  • 31
  • 0 comments

FDA approve PIMAVANSERIN

Comment Full text

AUROLIFE PHARMA LLC

  • FDA Approval
  • Jan. 17, 2024, 09:53 UTC
  • 34
  • 0 comments

FDA approve AMPHETAMINE SULFATE

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • Jan. 17, 2024, 09:53 UTC
  • 32
  • 0 comments

FDA approve DOCETAXEL

Comment Full text

SCIEGEN PHARMS INC

  • FDA Approval
  • Jan. 17, 2024, 09:53 UTC
  • 34
  • 0 comments

FDA approve OMEPRAZOLE; SODIUM BICARBONATE

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • Jan. 17, 2024, 09:53 UTC
  • 34
  • 0 comments

FDA approve DOCETAXEL

Comment Full text

DR REDDYS

  • FDA Approval
  • Jan. 17, 2024, 09:53 UTC
  • 34
  • 0 comments

FDA approve FENTANYL CITRATE

Comment Full text

KINDOS

  • FDA Approval
  • Jan. 17, 2024, 05:13 UTC
  • 35
  • 0 comments

FDA approve OXALIPLATIN

Comment Full text

REGENERON PHARMACEUTICALS

  • FDA Approval
  • Jan. 17, 2024, 02:05 UTC
  • 36
  • 0 comments

FDA approve DUPILUMAB

Comment Full text

HALOZYME THERAP

  • FDA Approval
  • Jan. 17, 2024, 02:05 UTC
  • 33
  • 0 comments

FDA approve HYALURONIDASE RECOMBINANT HUMAN

Comment Full text

BAUSCH AND LOMB

  • FDA Approval
  • Jan. 15, 2024, 11:24 UTC
  • 37
  • 0 comments

FDA approve HYALURONIDASE

Comment Full text
  • Previous
  • 573
  • 574
  • 575
  • 576
  • 577
  • Next

Search

News categories

  • Technical Exchange News(11766)
  • Event(4289)
  • SEC News(235917)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143375)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin